Cadrenal Therapeutics
CVKD
#9801
Rank
NZ$54.3 M
Marketcap
$28.89
Share price
-5.66%
Change (1 day)
90.95%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -$11.33

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -$12.40. In 2023 the company made an earnings per share (EPS) of -$16.60.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$11.33-31.77%
2023-$16.60